99 results
Page 2 of 5
8-K
EX-99.1
nerg p389edz5
16 Jul 21
Other Events
4:31pm
8-K
EX-99.4
5blpv r2itd
16 Jul 21
Other Events
4:31pm
8-K/A
EX-99.1
azywkdvq246ev6wcim
1 Jul 21
Changes in Registrant's Certifying Accountant
4:44pm
424B3
fbhp450l
11 May 21
Prospectus supplement
5:19pm
8-K
EX-99.1
cy0ak
24 Sep 20
Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist
8:33am
8-K
EX-99.1
x1upewzjgtpbrf
13 Jan 20
Results of Operations and Financial Condition
6:03am
424B5
esi6vbc6
5 Dec 19
Prospectus supplement for primary offering
4:06pm
424B5
1gnyvqnygc 28y75o
4 Dec 19
Prospectus supplement for primary offering
4:12pm